~~<i id='6508A8C1F5'><strike id='6508A8C1F5'><tt id='6508A8C1F5'><pre id='6508A8C1F5'></pre></tt></strike></i>~~

Home» explore» Wikipedia

Wikipedia

author：entertainment 2025-10-04 09:03:19 Page View：296

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： A year after a Russian missile took her leg, a young Ukrainian gymnast's spirit endures
Next article： Hepatitis C has a cure — but many Americans still lack access to it

leisure time

What does generative AI mean for health care? We asked experts

MikeReddyforSTATHealthcarecompaniesareracingtoincorporategenerativeAItoolsintotheirproductpipelinesa

Trump attorney outlines possible Jan. 6 legal defenses, but some experts are skeptical

9:45AttorneyforformerPresidentDonaldTrump,JohnLauro,speakstoABC'sGeorgeStephanopoulosonAug.6,2023,in

The high cost of giving birth even with insurance

AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

I learned firsthand about improving diversity in clinical trials

Asthebiopharmaceuticalindustryplacesincreasedemphasisonimprovingthediversityofparticipantsinclinical